The modest insider purchase indicates continued confidence from the Chairman, but given the small absolute size (~0.065% of market cap), it is not a strong trading catalyst. Monitor for further insider buying or any upcoming clinical catalysts that could drive more meaningful moves.
Price Chart
Executive Summary
OKYO Pharma Chairman Gabriele Cerrone, through Panetta Partners Ltd, purchased 22,500 ordinary shares at $1.45 per share, increasing his beneficial ownership to 10,873,916 shares (20.55% of outstanding). The ~$33,000 purchase is small relative to the $49M market cap but signals continued insider alignment at a clinical-stage biotech.
Key Financial Metrics
Key Facts
- Chairman Gabriele Cerrone purchased 22,500 ordinary shares at $1.45 per share
- Total holdings increased to 10,873,916 shares, representing 20.55% of issued share capital
- Purchase was executed through Panetta Partners Ltd, an entity in which Cerrone has a beneficial interest
- OKYO is a clinical-stage biopharmaceutical company developing therapies for neuropathic corneal pain and anterior segment eye diseases
Financial Impact
Approximately $32,625 total purchase consideration for 22,500 shares
Risk Factors
- Clinical-stage biotech risk with no approved products or revenue
- Small purchase size limits signal strength
- Prior insider purchases may not have prevented negative stock performance
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3331587 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 6, 2026 21d ago | 6-K | $1.46 $1.41 | ▼ −3.42% | ▼ −3.18% | $1.49 (+2.05%) |
Oct 6, 2026 21d ago | Press Release | $1.46 $1.41 | ▼ −3.42% | ▼ −3.18% | $1.49 (+2.05%) |
Sep 29, 2026 28d ago | 6-K | $1.36 $1.29 | ▼ −5.15% | ▼ −4.94% | $1.49 (+9.56%) |
Sep 8, 2026 7w ago | 6-K | $1.53 $1.45 | ▼ −5.23% | ▼ −4.76% | $1.49 (−2.61%) |
Aug 7, 2026 11w ago | Insider Cluster | $1.57 $1.52 | ▼ −3.18% | ▼ −2.87% | $1.49 (−5.10%) |
Jul 28, 2026 13w ago | 6-K | $1.64 $1.64 | · 0.00% | ▲ +1.54% | $1.49 (−9.15%) |
Jul 27, 2026 13w ago | 6-K | $1.64 $1.64 | · 0.00% | ▼ −0.24% | $1.49 (−9.15%) |
Jul 23, 2026 13w ago | 6-K | $1.48 $1.55 | ▲ +4.73% | ▲ +4.63% | $1.49 (+0.68%) |
Jul 23, 2026 13w ago | Press Release | $1.48 $1.55 | ▲ +4.73% | ▲ +4.63% | $1.49 (+0.68%) |
Jul 23, 2026 13w ago | 6-K | $1.48 $1.55 | ▲ +4.73% | ▲ +4.63% | $1.49 (+0.68%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers